Eli Lilly and Co. (LLY) emerged as a beacon of optimism last week in a market filled with uncertainty and volatility. Shares ...

Somatic Health and Kinetisense are launching a cutting edge clinical study in partnership with Rothman Orthopaedics to ...

Victorine Owira has been appointed as CEO of ACE Research effective April 2025. Victoria Tifft, co-founding member and CEO, will be transitioning to become a Strategic Advisor to the new CEO and Board ...

Victorine Owira brings over 20 years of hands on clinical research experience in managing clinical trials and leading ...

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Perfuze is currently in a Limited Market Release (LMR) in the United States with its FDA-cleared Millipede 088 Access ...

In this video interview, Rob Jones, product manager, TMF practice area, Pharmalex, discusses how risk-based approaches must be prioritized amidst the increased demand for quality and compliance.

The first Nexalin device has been shipped to São Paulo, Brazil, with additional units and single-use disposable electrodes scheduled for delivery in the coming days. These shipments support the launch ...

According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.